Alibaba Health fell slightly, Health 160 dropped by more than three percentage points, Hong Kong stock healthcare SaaS has been lacking catalysts lately; the US stock healthcare SPDR ETF rose by two percentage points🤔
Both are in healthcare, the US stock side ETF followed the broader market's style rotation and moved up, while the two on the Hong Kong stock side moved in the opposite direction—is it continued uncertainty over healthcare policies weighing on the Hong Kong stock side, or is it just a liquidity discount for Chinese concept healthcare stocks? It feels like the correlation between Hong Kong stocks and US stocks will remain relatively low until the healthcare policy window period ends.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
